Indian Rituximab Exporters: Complete Supplier Ranking with Market Share — 292 Manufacturers (2026) — TransData Nexus

Q: Who is the largest rituximab buyer importing from India?

JSC R-PHARM (RUSSIA) is the largest rituximab importer from India with a 34.6% market share and import value of $6.6M.

Q: How many rituximab buyers import from India?

There are 292 active rituximab buyers importing from India, with a combined import market of $19.1M across 1,215 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top rituximab buyers from India?

The top 5 rituximab buyers — JSC R-PHARM, STATE PHARMACEUTICALS CORPORATION, XXAROXXPHAXXA SXX DXXC V, STATE PHARMACEUTICALS CORPORATION O, LABORATORIOS LEGRAND S A — together control 48.3% of total rituximab import value from India.

Suresh Sormare

Rituximab

India Pharmaceutical Trade Intelligence

$19.1M164 Suppliers104 CountriesHS 30021500

ExportsIndia → RUSSIA47.2%India → SRI LANKA11.3%

ImportsGERMANY → India$4.0M SWITZERLAND → India$487.9K

#1 Buyer: JSC R-PHARM

Market Analysis: Top Importing Countries & Their Importers

1Russia

Russia emerges as the first largest importing country, achieving a total trade value of $9.0M through 11 shipments. This represents a market share of 47.2% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Russia has a diverse importer base, with their top importers including:

• JSC R-PHARM - $6.6M (73.3% of country's total business)

Key Insight: Russia demonstrates strong market positioning with an average shipment value of $820.3K, indicating premium pricing strategy compared to the market average of $15.7K.

Russia is a key market for Rituximab imports, representing 47.2% of total trade value.

Primary Market

Secondary Market

2Sri Lanka

Sri Lanka emerges as the second largest importing country, achieving a total trade value of $2.2M through 19 shipments. This represents a market share of 11.3% of the total market activity, demonstrating their significant presence in the industry.

Sri Lanka has a diverse importer base, with their top importers including:

Buyer Segment Analysis

TransData Nexus Rituximab buyer market intelligence

1Buyer Segment Analysis

The 292 buyers of Rituximab imported from India can be categorized into several segments:

1. Distributors: Entities that purchase Rituximab in bulk to supply to various healthcare providers. For instance, LABORATORIOS LEGRAND S.A. in Colombia, which imported Rituximab worth $0.58 million, likely operates as a distributor, supplying to multiple healthcare facilities.

2. Government Procurement Agencies: National bodies responsible for acquiring medications for public healthcare systems. The STATE PHARMACEUTICALS CORPORATION in Sri Lanka, with imports totaling $0.84 million, exemplifies this segment, procuring Rituximab for distribution across public hospitals.

3. Hospital Groups: Large healthcare institutions that import directly to meet their internal needs. While specific hospital groups are not listed among the top buyers, it's common for such entities to engage in direct procurement to ensure a steady supply for patient treatment.

4. Retail Chains: Pharmacy chains that import medications to stock their outlets. The data does not specify retail chains among the top buyers, suggesting that such entities may rely on local distributors for their supply.

5. Re-exporters: Companies that import Rituximab with the intent to export to other markets. SYNTEGON TECHNOLOGY GMBH in Germany, with imports worth $0.22 million, may function in this capacity, leveraging Germany's strategic position in the European pharmaceutical market.

6. Contract Manufacturers: Firms that import Rituximab as an active pharmaceutical ingredient (API) for formulation and packaging. The data does not highlight contract manufacturers among the top buyers, indicating that such activities might be more prevalent in other segments.

Country-Specific Import Regulations

TransData Nexus Rituximab buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Rituximab are as follows:

1. Russia:

Drug Regulatory Authority: Ministry of Health of the Russian Federation.

Import Registration Process: Requires submission of a registration dossier, including clinical trial data and quality documentation.

Estimated Timeline for Registration: Approximately 12 to 18 months.

Import Tariff/Duty for HS 30021500: Generally ranges from 5% to 10%, subject to specific trade agreements.

2. Sri Lanka:

Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

Import Registration Process: Submission of an application with product details, manufacturing information, and evidence of registration in the country of origin.

Demand Drivers & Market Opportunity

TransData Nexus Rituximab buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Rituximab in importing countries is driven by several factors:

1. Disease Prevalence: Rituximab is primarily used to treat B-cell malignancies such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia, as well as autoimmune diseases like rheumatoid arthritis. The increasing incidence of these conditions globally has led to a heightened demand for effective treatments.

2. Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at improving access to essential medicines. For example, the inclusion of Rituximab in national formularies and treatment guidelines facilitates its procurement and distribution.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased funding and support for the treatment of chronic and life-threatening diseases, thereby boosting the demand for medications like Rituximab.

4. WHO Essential Medicines List Procurement: The World Health Organization's Essential Medicines List serves as a guide for countries to prioritize the procurement of critical medications. The inclusion of Rituximab on this list underscores its importance and encourages its adoption in various healthcare systems.

5. Tender-Based Purchasing: Many governments and large healthcare institutions utilize tender systems to procure medications, ensuring cost-effectiveness and consistent supply. This approach often leads to bulk purchasing of drugs like Rituximab, contributing to its substantial import volumes.

The presence of 292 buyers across 104 countries indicates a widespread and growing market for Rituximab, reflecting its critical role in modern therapeutic regimens.

Common Questions — Rituximab Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest rituximab buyer importing from India?

Based on import volume and value, JSC R-PHARM (RUSSIA) leads with $6.6M in imports and a 34.6% market share — the highest of any single rituximab importer. STATE PHARMACEUTICALS CORPORATION (SRI LANKA) and XXAROXXPHAXXA SXX DXXC V (MEXICO) are the next largest buyers.

QHow many companies buy rituximab from India?

There are 292 active rituximab buyers importing from India, with a combined market of $19.1M across 1,215 shipments to 104 countries. The top 5 buyers hold 48.3% of total import value, while the remaining 287 buyers handle the other 51.7%.

QWhich countries import the most rituximab from India?

The top importing countries for rituximab from India are Russia (47.2%), Sri Lanka (11.3%), Colombia (6.1%), Venezuela (5.7%), Mexico (3.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of rituximab, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for rituximab from India?

The average import transaction value for rituximab from India is $15.7K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Rituximab buyer market intelligence

1Buyer Segment Analysis

The 292 buyers of Rituximab imported from India can be categorized into several segments:

Country-Specific Import Regulations

TransData Nexus Rituximab buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Rituximab are as follows:

1. Russia:

Drug Regulatory Authority: Ministry of Health of the Russian Federation.

Import Registration Process: Requires submission of a registration dossier, including clinical trial data and quality documentation.

Estimated Timeline for Registration: Approximately 12 to 18 months.

Import Tariff/Duty for HS 30021500: Generally ranges from 5% to 10%, subject to specific trade agreements.

2. Sri Lanka:

Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

Import Registration Process: Submission of an application with product details, manufacturing information, and evidence of registration in the country of origin.

Demand Drivers & Market Opportunity

TransData Nexus Rituximab buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Rituximab in importing countries is driven by several factors:

The presence of 292 buyers across 104 countries indicates a widespread and growing market for Rituximab, reflecting its critical role in modern therapeutic regimens.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Rituximab

Rituximab

Who Buys Rituximab from India — 292 Importers Behind a $19.1M Market

Top Rituximab Importers — Ranked by Import Value

Top Rituximab Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Rituximab — and from which countries?

Rituximab — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Russia

2Sri Lanka

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Rituximab Buyers & Importers

QWho is the largest rituximab buyer importing from India?

QHow many companies buy rituximab from India?

QWhich countries import the most rituximab from India?

QWhat is the average import order value for rituximab from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Colombia

4Venezuela

5Mexico

Analysis Methodology